AU1209501A - Method for treating parkinson's disease by administering (-)-5-keto-2-n,n-di-n-propylamino-tetrahydrotetralin - Google Patents

Method for treating parkinson's disease by administering (-)-5-keto-2-n,n-di-n-propylamino-tetrahydrotetralin

Info

Publication number
AU1209501A
AU1209501A AU12095/01A AU1209501A AU1209501A AU 1209501 A AU1209501 A AU 1209501A AU 12095/01 A AU12095/01 A AU 12095/01A AU 1209501 A AU1209501 A AU 1209501A AU 1209501 A AU1209501 A AU 1209501A
Authority
AU
Australia
Prior art keywords
tetrahydrotetralin
propylamino
keto
administering
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU12095/01A
Other languages
English (en)
Inventor
Durk Dijkstra
Leonard Theodore Meltzer
Bastiaan Johan Venhuis
Hakan Vilhelm Wikstrom
Lawrence David Wise
David Juergen Wustrow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of AU1209501A publication Critical patent/AU1209501A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/20—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU12095/01A 1999-10-20 2000-10-17 Method for treating parkinson's disease by administering (-)-5-keto-2-n,n-di-n-propylamino-tetrahydrotetralin Abandoned AU1209501A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16071699P 1999-10-20 1999-10-20
US60160716 1999-10-20
PCT/US2000/028685 WO2001028977A1 (en) 1999-10-20 2000-10-17 Method for treating parkinson's disease by administering (-)-5-keto-2-n,n-di-n-propylamino-tetrahydrotetralin

Publications (1)

Publication Number Publication Date
AU1209501A true AU1209501A (en) 2001-04-30

Family

ID=22578122

Family Applications (1)

Application Number Title Priority Date Filing Date
AU12095/01A Abandoned AU1209501A (en) 1999-10-20 2000-10-17 Method for treating parkinson's disease by administering (-)-5-keto-2-n,n-di-n-propylamino-tetrahydrotetralin

Country Status (8)

Country Link
AR (1) AR026086A1 (es)
AU (1) AU1209501A (es)
CO (1) CO5251402A1 (es)
GT (1) GT200000182A (es)
PA (1) PA8505301A1 (es)
PE (1) PE20010746A1 (es)
SV (1) SV2001000202A (es)
WO (1) WO2001028977A1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001248982B2 (en) * 2000-04-18 2005-12-15 H. Lundbeck A/S Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2065450A1 (en) * 1989-07-05 1991-01-06 James V. Peck Substituted 2-aminotetralins
WO2000006536A1 (en) * 1998-07-28 2000-02-10 Warner-Lambert Company Hexahydro-naphthalenone oximes and hydrazones

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001248982B2 (en) * 2000-04-18 2005-12-15 H. Lundbeck A/S Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use

Also Published As

Publication number Publication date
PE20010746A1 (es) 2001-07-27
AR026086A1 (es) 2002-12-26
GT200000182A (es) 2002-04-12
CO5251402A1 (es) 2003-02-28
SV2001000202A (es) 2001-10-16
WO2001028977A1 (en) 2001-04-26
PA8505301A1 (es) 2002-12-30

Similar Documents

Publication Publication Date Title
AU2001233299A1 (en) Methods for treating alzheimer's disease
AU1294401A (en) Methods for treating fibroproliferative diseases
ZA200203252B (en) Process for preparing 4"-substituted-9-deoxo-9A-AZA-9A-homoerythromycina derivatives.
ZA200201511B (en) 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents.
MXPA02001497A (es) Derivados de 3-(5)-ureido-pirazol, procedimiento para su preparacion y sus uso como agentes antitumorales.
AU1407399A (en) Treatment for alzheimer's disease
ZA200202521B (en) 2'-substituted 1,1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as a medicament and pharmaceutical preprations containing said compounds.
AU773240C (en) Medicament for treating hypertension
AU6932000A (en) Tacrine derivatives for treating alzheimer's disease
AU2042301A (en) 1-aminoalkyl-1H-indoles for treating glaucoma
AU3657100A (en) Use of water-soluble beta-(1,3) glucans as agents for producing therapeutic skintreatment agents
AU2002246490A1 (en) Method of treating parkinson's disease
ZA995444B (en) A method for the treatment of staphylococcal disease.
AU2002233220A1 (en) Medicament for preventing or treating tumors caused by human papilloma virus type 18
AU1405899A (en) Treatment for alzheimer's disease
IL139023A0 (en) Process for the preparation of 2,3,5-trimethyl-p- benzoquinone
IL142581A (en) Medicament for treating heart disease
AU1496597A (en) 1,1,2-triphenylbut-1-ene derivatives for treating Alzheimer's Disease
AUPP870999A0 (en) Method of treatment of equine disease
AU2851899A (en) Method for producing 2,2'-dihydroxybiphenyls
AU1209501A (en) Method for treating parkinson's disease by administering (-)-5-keto-2-n,n-di-n-propylamino-tetrahydrotetralin
AU6870500A (en) Process for the preparation of 2,3-dihydroazepine derivatives
AU6870600A (en) Process for the preparation of 2,3-dihydroazepine compounds
AU7773700A (en) Method for the production or preparation of 2,6-dichlorotoluol
HUP0004764A3 (en) Method for producing 4-methoxymethyl-2,3,5,6-tetrafluorobenzenealcohol

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase